Eleftha 150 (Trastuzumab Vials) 150mg

Eleftha 150 (Trastuzumab 150mg) is a monoclonal antibody vial used in cancer therapy. Store between 2-8°C and protect from light. Suitable for intravenous infusion under medical supervision. Short shelf life; check expiry before use.

Strength

150mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Intas Pharmaceuticals Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Eleftha 150 contains trastuzumab, a targeted therapy used to treat certain types of breast and stomach cancers. It works by binding to HER2 receptors to slow cancer cell growth. Often prescribed alongside chemotherapy for HER2-positive tumors. Also used in metastatic settings when cancer has spread.

Side Effects

Patients may experience infusion-related reactions such as fever, chills, or nausea during administration. Some report fatigue, headache, or digestive discomfort after treatment. These effects are typically temporary and monitored by healthcare providers.

Precautions & Warnings

Keep vials refrigerated at 2–8°C and avoid freezing. Protect from light during storage and handling. Inspect solution for particles or discoloration before use. Discard unused portion as per local regulations for cytotoxic drugs.

Avoid Interactions

Concurrent use with anthracyclines may increase cardiotoxicity risk. Live vaccines should be avoided during treatment. Caution advised with other HER2-targeted therapies or strong CYP450 inhibitors. Always inform your doctor about all medications being taken.

References

Frequently Asked Questions

Eleftha 150 is used to treat HER2-positive breast cancer and metastatic stomach cancer.

It is given as an intravenous infusion in a clinical setting by healthcare professionals.

Online purchase may be available from licensed pharmacies; prescription is required.

Common effects include fever, chills, nausea, and fatigue during or after infusion.

Store vials refrigerated between 2–8°C and protect from light.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.